{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:31:31Z","timestamp":1778884291851,"version":"3.51.4"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/mot.0000000000000095","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T12:36:49Z","timestamp":1402058209000},"page":"334-341","source":"Crossref","is-referenced-by-count":10,"title":["Megadose stem cell administration as a route to mixed chimerism"],"prefix":"10.1097","volume":"19","author":[{"given":"Noga","family":"Or-Geva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Reisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20211004","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/nm1295-1268","article-title":"Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice.","volume":"1","author":"Bachar-Lustig","year":"1995","journal-title":"Nat Med"},{"key":"R2-3-20211004","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-cell-depleted haploidentical three-loci incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum.","volume":"84","author":"Aversa","year":"1994","journal-title":"Blood"},{"key":"R3-3-20211004","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"key":"R4-3-20211004","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"key":"R5-3-20211004","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2002-04-1203","article-title":"Transplantation of highly purified CD34 progenitor cells from unrelated donors in pediatric leukemia.","volume":"101","author":"Lang","year":"2003","journal-title":"Blood"},{"key":"R6-3-20211004","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V73.7.2025.2025","article-title":"Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts.","volume":"73","author":"Lapidot","year":"1989","journal-title":"Blood"},{"key":"R7-3-20211004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-4613-1493-6_2","article-title":"Engraftment of T-cell-depleted bone marrow in murine models for allogeneic bone marrow transplantation.","volume":"50","author":"Reisner","year":"1990","journal-title":"Cancer Treat Res"},{"key":"R8-3-20211004","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood.V79.6.1612.1612","article-title":"Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation.","volume":"79","author":"Uharek","year":"1992","journal-title":"Blood"},{"key":"R9-3-20211004","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/00007890-199805270-00017","article-title":"Tolerance induction by megadose hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host antidonor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.","volume":"65","author":"Rachamim","year":"1998","journal-title":"Transplantation"},{"key":"R10-3-20211004","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1182\/blood.V99.11.4174","article-title":"Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34() cells.","volume":"99","author":"Gur","year":"2002","journal-title":"Blood"},{"key":"R11-3-20211004","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2002-11-3463","article-title":"Immune regulatory activity of CD34 progenitor cells: evidence for a deletion-based mechanism mediated by TNF-alpha.","volume":"105","author":"Gur","year":"2005","journal-title":"Blood"},{"key":"R12-3-20211004","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/287544a0","article-title":"An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it.","volume":"287","author":"Miller","year":"1980","journal-title":"Nature"},{"key":"R13-3-20211004","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1084\/jem.160.6.1702","article-title":"Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong antiself suppressive activity.","volume":"160","author":"Claesson","year":"1984","journal-title":"J Exp Med"},{"key":"R14-3-20211004","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.intimp.2008.12.009","article-title":"Induction of tolerance in organ recipients by hematopoietic stem cell transplantation.","volume":"9","author":"Ophir","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"R15-3-20211004","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1182\/blood-2012-02-410803","article-title":"Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7.","volume":"120","author":"Zangi","year":"2012","journal-title":"Blood"},{"key":"R16-3-20211004","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/cimm.2001.1771","article-title":"Veto activity of activated bone marrow does not require perforin and Fas ligand.","volume":"208","author":"Chrobak","year":"2001","journal-title":"Cell Immunol"},{"key":"R17-3-20211004","doi-asserted-by":"crossref","first-page":"6654","DOI":"10.4049\/jimmunol.173.11.6654","article-title":"Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells.","volume":"173","author":"Reich-Zeliger","year":"2004","journal-title":"J Immunol"},{"key":"R18-3-20211004","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.4049\/jimmunol.133.4.1769","article-title":"Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes.","volume":"133","author":"Fink","year":"1984","journal-title":"J Immunol"},{"key":"R19-3-20211004","first-page":"213","article-title":"Antiself suppressive (veto) activity of responder cells in mixed lymphocyte cultures.","volume":"126","author":"Claesson","year":"1986","journal-title":"Curr Top Microbiol Immunol"},{"key":"R20-3-20211004","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-3083.1989.tb01150.x","article-title":"Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. III. Direct correlation between development of syngeneic cytotoxicity and loss of veto activity; implications for the mechanism of veto action.","volume":"29","author":"Claesson","year":"1989","journal-title":"Scand J Immunol"},{"key":"R21-3-20211004","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.iy.06.040188.000555","article-title":"Veto cells.","volume":"6","author":"Fink","year":"1988","journal-title":"Annu Rev Immunol"},{"key":"R22-3-20211004","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood-2003-03-0759","article-title":"Antithird-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose.","volume":"102","author":"Bachar-Lustig","year":"2003","journal-title":"Blood"},{"key":"R23-3-20211004","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood.V88.3.962.962","article-title":"Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism.","volume":"88","author":"Martin","year":"1996","journal-title":"Blood"},{"key":"R24-3-20211004","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.4049\/jimmunol.179.10.6389","article-title":"Tolerance induction in presensitized bone marrow recipients by veto CTLs: Effective deletion of host antidonor memory effector cells.","volume":"179","author":"Reich-Zeliger","year":"2007","journal-title":"J Immunol"},{"key":"R25-3-20211004","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.4049\/jimmunol.169.7.3686","article-title":"T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection.","volume":"169","author":"Pantenburg","year":"2002","journal-title":"J Immunol"},{"key":"R26-3-20211004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm965","article-title":"Homeostatic proliferation is a barrier to transplantation tolerance.","volume":"10","author":"Wu","year":"2004","journal-title":"Nat Med"},{"key":"R27-3-20211004","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4049\/jimmunol.176.1.329","article-title":"Specificity of CD4CD25 regulatory T cell function in alloimmunity.","volume":"176","author":"Sanchez-Fueyo","year":"2006","journal-title":"J Immunol"},{"key":"R28-3-20211004","doi-asserted-by":"crossref","first-page":"19954","DOI":"10.1073\/pnas.0704397104","article-title":"Allograft rejection mediated by memory T cells is resistant to regulation.","volume":"104","author":"Yang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-3-20211004","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI200317477","article-title":"Heterologous immunity provides a potent barrier to transplantation tolerance.","volume":"111","author":"Adams","year":"2003","journal-title":"J Clin Invest"},{"key":"R30-3-20211004","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.4049\/jimmunol.172.9.5456","article-title":"In vivo helper functions of alloreactive memory CD4 T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.","volume":"172","author":"Chen","year":"2004","journal-title":"J Immunol"},{"key":"R31-3-20211004","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1074-7613(00)00050-9","article-title":"Antithird party CD8 CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite.","volume":"13","author":"Reich-Zeliger","year":"2000","journal-title":"Immunity"},{"key":"R32-3-20211004","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.4049\/jimmunol.173.11.6660","article-title":"Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis.","volume":"173","author":"Reich-Zeliger","year":"2004","journal-title":"J Immunol"},{"key":"R33-3-20211004","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2010-05-283770","article-title":"CTLs respond with activation and granule secretion when serving target for T cell recognition.","volume":"117","author":"Milstein","year":"2010","journal-title":"Blood"},{"key":"R34-3-20211004","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/01.tp.0000185302.38890.6b","article-title":"Rapamycin prolongs susceptibility of responding T cells to tolerance induction by CD8 veto cells.","volume":"81","author":"Anderson","year":"2006","journal-title":"Transplantation"},{"key":"R35-3-20211004","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood-2009-10-248716","article-title":"Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cells.","volume":"115","author":"Ophir","year":"2010","journal-title":"Blood"},{"key":"R36-3-20211004","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1172\/JCI13296","article-title":"Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes.","volume":"108","author":"Manjunath","year":"2001","journal-title":"J Clin Invest"},{"key":"R37-3-20211004","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.4049\/jimmunol.172.12.7315","article-title":"Initial antigen encounter programs CD8 T cells competent to develop into memory cells that are activated in an antigen-free, IL-7- and IL-15-rich environment.","volume":"172","author":"Carrio","year":"2004","journal-title":"J Immunol"},{"key":"R38-3-20211004","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.1073\/pnas.0503726102","article-title":"Central memory selftumor-reactive CD8 T cells confer superior antitumor immunity compared with effector memory T cells.","volume":"102","author":"Klebanoff","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R39-3-20211004","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"R40-3-20211004","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.194.7.953","article-title":"Migratory properties of naive, effector, and memory Cd8 T cells.","volume":"194","author":"Weninger","year":"2001","journal-title":"J Exp Med"},{"key":"R41-3-20211004","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets.","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat Immunol"},{"key":"R42-3-20211004","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1002\/eji.200838426","article-title":"Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy.","volume":"38","author":"Mueller","year":"2008","journal-title":"Eur J Immunol"},{"key":"R43-3-20211004","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/blood-2012-07-441493","article-title":"Murine antithird-party central-memory CD8() T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of antidonor T cells.","volume":"121","author":"Ophir","year":"2013","journal-title":"Blood"},{"key":"R44-3-20211004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.smim.2011.05.001","article-title":"Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction.","volume":"23","author":"Strober","year":"2011","journal-title":"Semin Immunol"},{"key":"R45-3-20211004","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/00007890-200205150-00005","article-title":"Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation.","volume":"73","author":"Millan","year":"2002","journal-title":"Transplantation"},{"key":"R46-3-20211004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.1979.tb00285.x","article-title":"Allograft tolerance after total lymphoid irradiation (TLI).","volume":"46","author":"Strober","year":"1979","journal-title":"Immunol Rev"},{"key":"R47-3-20211004","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199910150-00023","article-title":"Comparison of chimeric acid and nonchimeric tolerance using posttransplant total lymphoid irradiation: cytokine expression and chronic rejection.","volume":"68","author":"Hayamizu","year":"1999","journal-title":"Transplantation"},{"key":"R48-3-20211004","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(85)92624-8","article-title":"Treatment of cadaveric renal transplant recipients with total lymphoid irradiation, antithymocyte globulin, and low-dose prednisone.","volume":"2","author":"Levin","year":"1985","journal-title":"Lancet"},{"key":"R49-3-20211004","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00007890-198803000-00008","article-title":"Clinical and immunological studies of cadaveric renal transplant recipients given total-lymphoid irradiation and maintained on low-dose prednisone.","volume":"45","author":"Saper","year":"1988","journal-title":"Transplantation"},{"key":"R50-3-20211004","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJM198907063210106","article-title":"Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation.","volume":"321","author":"Strober","year":"1989","journal-title":"N Engl J Med"},{"key":"R51-3-20211004","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/00007890-200004270-00005","article-title":"Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and antidonor reactivity.","volume":"69","author":"Strober","year":"2000","journal-title":"Transplantation"},{"key":"R52-3-20211004","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MOH.0b013e3283319e8f","article-title":"Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update.","volume":"16","author":"Kohrt","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"R53-3-20211004","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1182\/blood-2009-03-211441","article-title":"TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.","volume":"114","author":"Kohrt","year":"2009","journal-title":"Blood"},{"key":"R54-3-20211004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa074191","article-title":"Tolerance and chimerism after renal and hematopoietic-cell transplantation.","volume":"358","author":"Scandling","year":"2008","journal-title":"N Engl J Med"},{"key":"R55-3-20211004","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1600-6143.2012.03992.x","article-title":"Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants.","volume":"12","author":"Scandling","year":"2012","journal-title":"Am J Transplant"},{"key":"R56-3-20211004","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00007890-199908270-00006","article-title":"Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism.","volume":"68","author":"Spitzer","year":"1999","journal-title":"Transplantation"},{"key":"R57-3-20211004","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/j.1600-6143.2006.01434.x","article-title":"Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.","volume":"6","author":"Fudaba","year":"2006","journal-title":"Am J Transplant"},{"key":"R58-3-20211004","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/TP.0b013e31820a3068","article-title":"Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease.","volume":"91","author":"Spitzer","year":"2011","journal-title":"Transplantation"},{"key":"R59-3-20211004","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/bbmt.1999.v5.pm10392959","article-title":"Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.","volume":"5","author":"Pelot","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"R60-3-20211004","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2002-01-0023","article-title":"Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells.","volume":"100","author":"Mapara","year":"2002","journal-title":"Blood"},{"key":"R61-3-20211004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.TP.0000072014.83469.2D","article-title":"Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism.","volume":"76","author":"Mapara","year":"2003","journal-title":"Transplantation"},{"key":"R62-3-20211004","doi-asserted-by":"crossref","first-page":"a015529","DOI":"10.1101\/cshperspect.a015529","article-title":"Induction of tolerance through mixed chimerism.","volume":"4","author":"Sachs","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3A","key":"R63-3-20211004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1083-8791(00)70056-5","article-title":"Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.","volume":"6","author":"Spitzer","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"R64-3-20211004","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1097\/01.TP.0000064211.23536.AD","article-title":"Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies.","volume":"75","author":"Spitzer","year":"2003","journal-title":"Transplantation"},{"key":"R65-3-20211004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.bmt.1705688","article-title":"Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen.","volume":"40","author":"Dey","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R66-3-20211004","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa071074","article-title":"HLA-mismatched renal transplantation without maintenance immunosuppression.","volume":"358","author":"Kawai","year":"2008","journal-title":"N Engl J Med"},{"key":"R67-3-20211004","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1600-6143.2011.03566.x","article-title":"Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrowkidney transplantation.","volume":"11","author":"Andreola","year":"2011","journal-title":"Am J Transplant"},{"key":"R68-3-20211004","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMc1213779","article-title":"HLA-mismatched renal transplantation without maintenance immunosuppression.","volume":"368","author":"Kawai","year":"2013","journal-title":"N Engl J Med"},{"key":"R69-3-20211004","first-page":"124fs5","article-title":"The quest for transplantation tolerance: have we finally sipped from the cup Sci Transl M","volume":"4","author":"Markmann","year":"2012","journal-title":"ed"},{"key":"R70-3-20211004","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bmt.1703015","article-title":"Engraftment syndrome following hematopoietic stem cell transplantation.","volume":"27","author":"Spitzer","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R71-3-20211004","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1600-6143.2011.03572.x","article-title":"Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts.","volume":"11","author":"Farris","year":"2011","journal-title":"Am J Transplant"},{"key":"R72-3-20211004","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1182\/blood.V84.8.2436.2436","article-title":"Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells.","volume":"84","author":"Kaufman","year":"1994","journal-title":"Blood"},{"key":"R73-3-20211004","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1084\/jem.20041399","article-title":"Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment.","volume":"201","author":"Fugier-Vivier","year":"2005","journal-title":"J Exp Med"},{"key":"R74-3-20211004","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.critrevonc.2006.06.011","article-title":"Facilitating cells: novel promoters of stem cell alloengraftment and donor-specific transplantation tolerance in the absence of GVHD.","volume":"61","author":"Colson","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"R75-3-20211004","doi-asserted-by":"crossref","first-page":"124ra28","DOI":"10.1126\/scitranslmed.3003509","article-title":"Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.","volume":"4","author":"Leventhal","year":"2012","journal-title":"Sci Transl Med"},{"key":"R76-3-20211004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/TP.0b013e3182782fc1","article-title":"Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.","volume":"95","author":"Leventhal","year":"2013","journal-title":"Transplantation"},{"key":"R77-3-20211004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1741-7015-10-48","article-title":"Novel regulatory therapies for prevention of graft-versus-host disease.","volume":"10","author":"Leventhal","year":"2012","journal-title":"BMC Med"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-201408000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:49:39Z","timestamp":1689295779000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201408000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0000000000000095","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}